Platelet and endothelial cell function in patients with insulin-dependent diabetes mellitus with excellent, good, or poor metabolic control

Microvascular Research

Volumn 52, Issue 2, 1996, Pages 183-187

  Wagner, B ^a   Fasching, P ^a   Schneider, B ^a   Kurzemann, S ^a   Waldhaus W ^a   Lechner, K ^a   Kyrle, P A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; BLEEDING TIME; BLOOD SAMPLING; CLINICAL ARTICLE; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION;

EID: 0030250263     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1996.0053     Document Type: Article

References (17)

1. Bohlen, G. H., and Lash, J. M. (1993). EDRF-mediated vasodilation of normal rat arterioles. Am. J. Physiol. 265, H219-H225.
2. Borsey, D. Q., Dawes, J., Fraser, D. M., Prowse, C. V., Elton, R. A., and Clarke, B. F. (1980). Plasma β-thromboglobulin in diabetes mellitus. Diabetologia 18, 353-357.
3. Collier, A., Tymkewycz, P., Armstrong, R., Young, R. J., Joner, R. L., and Clarke, B. F. (1986). Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy. Diabetologia 29, 471-474.
4. α in humans in response to a standardized vascular injury and the influence of aspirin. Circulation 79, 29-38.
5. Gresele, P., Arnout, J., Deckmyn, J., Huybrechts, E., Pieters, G., and Vermylen, J. (1987). Role of proaggregatory and antiaggregatory prostaglandins in hemostasis - Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. J. Clin. Invest. 80, 1435-1445.
6. 2 generation by low-dose aspirin at the site of plug formation in man in vivo. Circulation 75, 1025-1029.
7. Nowak, J., and Fitzgerald, G. (1989). Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. J. Clin. Invest. 83, 380-385.
8. Nievelstein, P. F., Sixma, J. J., Ottenhof-Rovers, M., Wynne, H. J., De Groot, P. G., Mielke, C. H., Kaneshiro, M. M., Mahler, I. A., Weiner, J. M., and Rapaport, S. I. (1969). The standardized Ivy bleeding time and its prolongation by aspirin. Blood 34, 204-215.
9. O'Donnell, M. J., Le Guen, C. A., Lawson, N., Gyde, O. H., and Barnett, A. H. (1991). Platelet behavior and heamostatic variables in type I (insulin dependent) diabetic patients with and without albuminuria. Diabetic. Med. 8(7), 624-628.
10. Ono, H., Umeda, F., Inoguchi, T., and Ibayashi, H. (1990). Glucose inhibits prostacyclin production by cultured aortic endothelial cells. Thromb. Haemostas. 60, 174-177.
11. Ostermann, H., and van de Loo, J. (1986). Factors of the hemostatic system in diabetic patients. A survey of controlled studies. Heamostasis 16(6), 386-416.
12. Stehouwer, C. D., Stroes, E. S., Hackeng, W. H., Mulder, P. G., and Den Ottolander, G. J. (1991). Von Willebrand Factor and development of diabetic nephropathy in IDDM. Diabetes 40, 971-976.
13. The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Eng. J. Med. 329, 977-986.
14. The Eurodiab IDDM Complications Study Group (Stephenson, J., and Fuller, J. H.) (1994). Microvascular and acute complications in IDDM patients: The Eurodiab IDDM Complications Study. Diabetologia 37, 278-285.
15. White, A. M., and Heptinstall, S. (1978). The contribution of platelets to thrombosis. Br. Med. Bull. 34, 123-128.
16. Winer, B. J. (1971). Statistical Principles in Experimental Design. McGraw Hill, New York.
17. 2 by diabetic platelets. Eur. J. Clin. Invest. 9, 223-228.